INTRODUCTION
During translation, elongation factor Tu (EF-Tu) promotes the GTP-dependent binding of aminoacyltRNA to the ribosome (Miller & Weissbach, 1977) . Due to this essential role in protein biosynthesis, EF-Tu has been extensively investigated structurally and functionally (Berchtold et al., 1993; Nissen et al., 1995; Weijland & Parmeggiani, 1994) . In addition, tuf genes have been widely used as a tool to determine phylogenetic relationships (Filer & Furano, 1980 , 1981a Sela et al., 1989; Wenzig & Schleifer, 1989; Ludwig et al., 1990; Baldauf et al., 1996) .
Our laboratory recently characterized mAb 900, which recognized an epitope of EF-Tu in organisms from both the bacterial and archaeal domains but not in those from the eukaryote domain (Weber et al., 1995) . However, although mAb 900 recognized more than 90 different species belonging to either the bacterial or archaeal domains, some species within a given phylum were not recognized while other, more distantly related species from other phyla were recognized.
To understand the basis of the patterns of reactivity of mAb 900 we first mapped the epitope of mAb 900 using SPOTScan analysis, EF-Tu domain analysis, and sitedirected mutagenesis of the EF-Tu domain of Mycoplasma hominis. We then used this sequence information to analyse EF-Tu sequences from the SWISS-PROT database. (NCTC 101 ll) , Mycoplasma pneumoniae (NCTC 101 19), Mycoplasma gallisepticum (NCTC 101 15) and Mycoplasma genitalium (NCTC 10120) were obtained from the National Collection of Type Cultures, London, UK). The strains were grown at 37 "C in 200 ml cellculture flasks (Nunc) containing 100 ml culture medium as described previously (Schmitt et al., 1988) . Deinococcus radiodurans ' sark', Deinococcus radiophilus and Deinobacter grandis were kindly provided by R. G. E. Murray Table 1 were obtained as described previously (Weber et al., 1995) . EF-Tu domains of Thermus thermophilus. The EF-Tu molecule consists of three distinct domains according to the X-ray crystallographic model : domain 1 (residues 1-200), domain 2 (residues 201-299) and domain 3 (residues 300-393) (Kjeldgaard & Nyborg, 1992) . The EF-Tu domains of T. thermophilus were purified using anion-exchange chromatography on Q-Sepharose Fast Flow (Pharmacia) and gel filtration through Sephacryl S-200 (Pharmacia) as described by Nock et al. (1995) . Purified domains 1, 1 and 2, and 3 were subjected to SDS-PAGE (12-5 ' / o polyacrylamide) and were either stained with silver nitrate or used for Western blot analysis with mAb 900. The purified EF-Tu domains of T. thermophilus were kindly provided by S. Nock and M. Sprinzl (Lehrstuhl fur Biochemie, Universitat Bayreuth, Germany). Peptide synthesis. Peptides were synthesized as arrays of Nterminally acylated and C-terminally covalently immobilized products on cellulose sheets derivatized with PAla-PAla dipeptide anchors by the spot synthesis technique as described by Frank (1992) and Frank & Overwin (1996) using a model ASP 222 spotting robot (ABIMED Analysen-Technik). Binding of mAb 900 to peptide spots was assayed as described by Frank & Overwin (1996) using a goat-anti-mouse secondary antibody conjugate with alkaline phosphatase. Peptide arrays included (i) overlapping pentadecapeptides with an offset of 2 or 5 amino acid residues resulting in either 77 (5 residue offset) or 190 (2 residue offset) different peptides, spanning the whole 393 amino acid sequence of EF-Tu (SPOTScan analysis), (ii) overlapping peptides of stepwise reduced length with an offset of only 1 amino acid residue spanning the N-terminal 15 residues of EF-Tu (SPOTSize analysis), and (iii) systematic single amino acid replacement analogues (SPOTSalogue analysis) of the minimal hexapeptide epitope. SDSPAGE and immunoblotting. SDS-PAGE was performed according to the method of Laemmli (1970) . After addition of the sample buffer, the sample solution was boiled for 5 min and proteins separated by SDS-PAGE through 12.5 '/o polyacrylamide gels. Subsequently, proteins were stained with silver nitrate. For immunoblotting, the proteins were electrotransferred to a nitrocellulose membrane (0.45 pm pore size; Schleicher & Schull) and then incubated for 2 h with mAb 900 at room temperature. Binding was detected by incubation of the membrane with biotinylated anti-mouse immunoglobulin antibody (Amersham), diluted 1:lOOO in PBS (001 M NaH,P04/Na,HP04)/1% BSA, for 1 h at room temperature, followed by incubation with avidin horseradish peroxidase (Sigma) for 30 min at room temperature. The Western blot was developed using 4-chloro-l-naphthol (Sigma) as substrate. Release of EF-TU from deinococci. Deinococci were grown in Luria-Bertani (LB) medium until the OD,,, of the culture reached 1.0. Bacteria were harvested by centrifugation and resuspended in 100 p110 mM PBS, pH 7.5. Bacterial cell walls were disrupted using glass beads as described by Weber et al. (1995) . The bacterial lysates (15 pl) were either directly added to an equal amount of SDS sample buffer and used for SDS-PAGE or stored at -70 OC until use. Sitedirected mutagenesis and expression of EF-Tu domain 1 of M. horninis. Mutagenesis of the N terminus of EF-Tu domain 1 of M. hominis was performed by PCR. Oligonucleotides JK 88 (5' GTC CTC GCA ACT GCG GCC CAG CCG GCC ATG GCC AAA GAA AAA TTT GAA CGT TCA AAA CC 3') (5' primer) and JK 91 (5' G AGA GAG AGA AAG CTT TTA TTA GAT GTA TGT ATC AAC AGC C 3') (3' primer) were used to amplify a 609 bp fragment encoding the mutated EF-Tu domain 1. Primer JK 88 introduced three amino acid replacements at positions 3 , 4 and 6: Glu for Leu, Lys for Asp and Glu for Asp, respectively. Plasmid pMHEL2 (kindly provided by E. Luneberg, Institut fur Hygiene und Mikrobiologie, Wurzburg, Germany), which contains the whole gene encoding the EF-Tu sequence of M . hominis (Luneberg et al., 1991) , served as template. The amplified EFTu fragment was digested with NcoI and Hind111 and cloned into the expression vector pTrc99A (Pharmacia Biotech) using standard protocols (Sambrook et al., 1989) . DNA sequencing confirmed the expected amino acid sequence of the mutated fragment. Subsequently, the plasmid harbouring the mutated EF-Tu domain 1 sequence of M . hominis (pTUMB 1) was used to transform electroporation-competent T G l cells (Stratagene). In addition, TG1 cells were transformed with pTrc99A without an insert. For expression, TG1 cells were grown overnight in 2 x TY broth (0.1 YO tryptone, 0.05 YO yeast extract, 0.8% NaCl be added on proof) containing 100 pg ampicillin ml-I (2 x TY-AMP). The next day, 0.5 ml of the overnight culture was added to 4.5 ml fresh 2 x TY-AMP broth containing 1 mM IPTG. Bacteria were grown for 3 h at 37 OC. The culture was then centrifuged at 5000 g for 10 min. The pelleted cells were resuspended in SDS sample buffer and boiled for 5 min before separation of the proteins by SDS-PAGE through a 15 ' / o polyacrylamide gel. Amino acid alignment. This was performed using the PC GENE program (IntelliGenetics) and the SWISS-PROT protein sequence database.
METHODS

Micro-organisms. M . hominis
RESULTS AND DISCUSSION
Binding sites of mAb 900 identified by SPOTScan and domain analysis
MAb 900 recognized EF-Tu in Western blots, indicating that it detects a continuous epitope of the EF-Tu molecule. As shown in Fig. 1 , SPOTScan analysis showed that mAb 900 bound to three different regions within the EF-Tu molecule. The strongest signal was obtained with the very N-terminal peptide SKEKFER-TKPHVNVG. However, the adjacent peptides, lacking either the first two or five N-terminal residues were not detected. This result strongly suggested that the first two N-terminal residues were essential for mAb 900 binding
The second region detected comprised two peptides. The consensus motif of these peptides was GAARAF-DQID (amino acid positions 41-50; Fig. 1 ). This region is part of the effector region of EF-Tu, which interacts with the ribosome (Berchtold et al., 1993) . In 7'. thermophilus it has been demonstrated that the effector region can be divided into two segments, positions 41-49 and positions 5 4 4 0 , with the latter region wellconserved between species. In contrast, positions 41-49 are the most variable between species. Thus, the peptide sequence ARAFDQIDN may be a distinct, alternative epitope ligand structure recognized by mAb 900, but it is unlikely to be the highly conserved epitope detected by mAb 900 throughout the bacterial superkingdom.
to EF-Tu.
A conserved amino-terminal epitope of EF-Tu Taken together, the results of the SPOTScan analysis and the Western blot analysis strongly suggested that the N terminus of the EF-Tu molecule was the highly conserved sequence recognized by mAb 900 within the bacterial and archaeal domains (Weber et al., 1995) .
Definition of the binding epitope of mAb 900 using SPOTSize and SPOTSalogue analysis
To determine the epitope boundaries of mAb 900, we performed SPOTSize analysis. T o localize the C-terminal boundary of the epitope within the N-terminal15 mer peptide, we successively truncated the peptide Cterminally to the tetramer SKEK. The shortest peptide detected by mAb 900 was the hexamer SKEKFE (Fig. 2) . The previous SPOTScan analysis had revealed that N- terminal truncation of two residues completely abrogated mAb 900 binding. To evaluate whether the full length of six amino acids was indispensable for antibody binding, the N-terminal serine was deleted and found to reduce binding (data not shown).
It is well-known that within a particular epitope not all residues bind with equivalent affinity to an antibody (Appel et al., 1990) . To determine the key residues within the EF-Tu epitope, replacement analysis was performed using the SPOTSalogue technique. Within the peptide SKEKFE, every position was replaced by all other 19 naturally occurring amino acids (Fig. 3 ). This analysis demonstrated that both the C-terminal residues, phenylalanine and glutamic acid, were indispensable for mAb 900 binding. Only conservative replacements (Trp or Tyr for Phe' or Asp for G l d ) were tolerated at these positions, whereas residues in positions 1-4 could be substituted by nearly every other amino acid when single amino acid replacements were performed.
Sitedirected mutagenesis of EF-Tu domain 1 of M.
hominis EF-Tu of M. hominis is not recognized by mAb 900 (Weber et al., 1995) . The N-terminal sequences of E. coli and M. hominis differ at four positions, 1 , 3 , 4 and 6. T o evaluate whether the N-terminal E. coli sequence SKEKFE alone was sufficient to change the EF-Tu molecule of M . hominis to one recognized by mAb 900, we performed site-directed mutagenesis of EF-Tu domain 1 of M . hominis. Amino acids at positions 3 , 4 and 6 were replaced by those of E. coli. As alanine occurs in position 1 of the epitope recognized by mAb 900 in many species (e.g. Bacteroides fragilis or Pseudomonas aeruginosa, see Table l) , it was not modified. The mutated domain 1 of M . hominis was recognized by mAb 900 (Fig. 4) indicating that the N-terminal sequence SKEKFE was the epitope of mAb 900 and confirming the data obtained by the SPOTSalogue analysis.
Distribution of the epitope within the bacterial and archaeal domains
Comparison of the epitope sequences of different species listed in the SWISS-PROT database revealed that positions 1, 2, 4, 5 and 6 were highly conserved. The most important residues for mAb 900 binding, i.e. phenylalanine at position 5 or glutamic/aspartic acid at position 6, occur in 91% and 71% of species, respectively. At positions 2 and 4, 91% and 66% of residues are arginine/lysine and lysine, respectively. However, serine at position 1 is found only in about 13 % of species. In fact, most often (80 Yo of species) the residue in this position is alanine, which obviously does not inhibit mAb 900 binding (Fig. 3) . Glutamic acid at position 3 is found only in about 30% of species. It is replaced by several other amino acids, most commonly by alanine or glycine. None of these replacements changed the binding properties of mAb 900 ( Fig. 3 ; Table 1 ).
In a previous study we found that mAb 900 does not recognize some closely related species within a given phylum (Weber et al., 1995 radiodurans and found all species to be recognized by mAb 900 (Table 1) . Unfortunately, no EF-Tu sequences have yet been published from these bacteria.
Currently two EF-Tu sequences of archaea are available,
i.e. those of Methanococcus vannielii and Haloarcula marismortui. The latter species was detected in Western blots by mAb 900 (Weber et al., 1995) . However, neither the epitope sequence SKEKFE nor the other sequences detected by the SPOTScan analysis can be found within these EF-Tu sequences. However, at positions 47-53 of archaeal EF-Tu the sequence KGKGGFE is located, and this may mimic the SKEKFE epitope and thus serve as a binding domain for mAb 900. This view is supported by the fact that the KGK motif also occurs in Burkholderia cepacia, an EF-Tu sequence which is detected by mAb 900 (Table 1 ). The glycine residues allow for a free rotation so that the key residues Phe and Glu may come in close contact with the KGK sequence, which allows them to fit into the antigen-binding site of mAb 900.
When we performed a similarity scan, we found a perfect match of the KEKFE sub-sequence to the alphasubunit of methyl-coenzyme M reductase of M . vannielii at the N terminus of the molecule. The molecular mass of this protein is 61 kDa. Although we did not test M. uannielii for reactivity with mAb 900, this protein may also occur in other Euryarchaeota. The cross-reactivity to this protein could explain why mAb 900 stained a band of 60-80 kDa but not of 45 kDa in Western blots performed with different archaea (Weber et al., 1995) .
In addition to the hitherto tested archaea, six species from the ' hyperthermophilic ' archaea, Archaeoglobus fulgidus, Pyrobaculum aerophilum, Methanococcus igneus, Methano p yrus kandleri, Methanothermus feruidus and Pyrodictium abyssii, were investigated. O f these, A. fulgidus (two bands at 45 kDa and 70 kDa) and P. aerophilurn (two bands at approx. 60 kDa) were detected by mAb 900 (data not shown). The fact that P. aerophilum belongs to the order Thermoproteales within the crenarchaeotal kingdom suggests that the epitope of mAb 900 is even present in this kingdom. In summary, we mapped the epitope of mAb 900 to the N-terminal EF-Tu residues SKEKFE, a sequence which is highly conserved in the bacterial domain. Using the SPOTSalogue technique, the key residues Phe5 and Glu' were identified. This information allowed us to address the failure of mAb 900 to recognize some closely related species within a given phylum. At the moment, we cannot be certain whether the sequence occurs in the archaeal elongation factor or whether the positive staining in Western blots is due to cross-reaction with other proteins.
